Total Payments
$4,578
2024 Payments
$20.31
Companies
23
Transactions
86
Medicare Patients
3,701
Medicare Billing
$860,718
Payment Breakdown by Category
Food & Beverage$4,557 (99.6%)
Education$20.39 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,557 | 83 | 99.6% |
| Education | $20.39 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $922.15 | 28 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $726.09 | 8 | $0 (2020) |
| Novo Nordisk Inc | $389.29 | 10 | $0 (2020) |
| Dexcom, Inc. | $287.75 | 6 | $0 (2020) |
| Celgene Corporation | $262.07 | 2 | $0 (2018) |
| Horizon Pharma plc | $250.02 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $243.64 | 2 | $0 (2019) |
| Medtronic MiniMed, Inc. | $160.33 | 2 | $0 (2019) |
| Cardiovascular Systems Inc. | $148.46 | 2 | $0 (2017) |
| Abbott Laboratories | $144.23 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.31 | 1 | Chiesi USA, Inc. ($20.31) |
| 2022 | $245.79 | 5 | Lilly USA, LLC ($125.00) |
| 2020 | $331.57 | 8 | Novo Nordisk Inc ($186.86) |
| 2019 | $1,009 | 20 | AstraZeneca Pharmaceuticals LP ($260.36) |
| 2018 | $1,318 | 27 | Lilly USA, LLC ($287.45) |
| 2017 | $1,653 | 25 | Lilly USA, LLC ($225.76) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2024 | Chiesi USA, Inc. | MYALEPT (Drug) | Food and Beverage | Cash or cash equivalent | $20.31 | General |
| Category: GENERALIZED LIPODYSTROPHY | ||||||
| 10/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: DIABETES | ||||||
| 10/11/2022 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $59.54 | General |
| Category: Durable Pump | ||||||
| 07/21/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 05/10/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: DIABETES | ||||||
| 03/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: DIABETES | ||||||
| 09/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 08/05/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Diabetes | ||||||
| 05/21/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $100.01 | General |
| 02/27/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 02/08/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Diabetes | ||||||
| 01/30/2020 | Dexcom, Inc. | DEXCOM G6 CGM SYSTEM (Device) | Food and Beverage | In-kind items and services | $77.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/10/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Diabetes | ||||||
| 12/06/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Diabetes | ||||||
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes | ||||||
| 09/24/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $105.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Diabetes | ||||||
| 08/15/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Durable Pump | ||||||
| 07/17/2019 | Lilly USA, LLC | — | Education | In-kind items and services | $8.35 | General |
| 05/23/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $76.55 | General |
| Category: Diabetes | ||||||
| 05/23/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes | ||||||
| 05/23/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Diabetes | ||||||
| 05/21/2019 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 676 | 1,884 | $666,427 | $164,450 |
| 2022 | 11 | 1,076 | 3,366 | $1.2M | $277,289 |
| 2021 | 8 | 901 | 2,036 | $750,796 | $180,943 |
| 2020 | 12 | 1,048 | 2,822 | $988,663 | $238,036 |
Total Patients
3,701
Total Services
10,108
Medicare Billing
$860,718
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 145 | 981 | $267,813 | $72,519 | 27.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 240 | $94,560 | $26,681 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 151 | 259 | $106,449 | $22,461 | 21.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 104 | 128 | $98,688 | $20,728 | 21.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 67 | $34,974 | $8,130 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 71 | 95 | $26,315 | $5,245 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 25 | $13,925 | $3,217 | 23.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 31 | 62 | $9,114 | $2,925 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $9,525 | $1,669 | 17.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $5,064 | $874.79 | 17.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 262 | 1,817 | $496,041 | $121,131 | 24.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 150 | 529 | $208,426 | $51,048 | 24.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 186 | 236 | $181,956 | $43,544 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 178 | 346 | $142,206 | $29,447 | 20.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 86 | 101 | $52,722 | $12,720 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 113 | 164 | $45,428 | $8,800 | 19.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 40 | 107 | $15,729 | $3,935 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 22 | $12,254 | $2,399 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $10,795 | $2,078 | 19.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 14 | 15 | $6,315 | $1,303 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 12 | 12 | $5,064 | $883.82 | 17.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 200 | 890 | $242,970 | $60,840 | 25.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 114 | 347 | $136,718 | $34,204 | 25.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 130 | 161 | $124,131 | $30,509 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 144 | 236 | $96,996 | $21,930 | 22.6% |
About Dr. Judith Giunta, M.D
Dr. Judith Giunta, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2011. The National Provider Identifier (NPI) number assigned to this provider is 1386940385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judith Giunta, M.D has received a total of $4,578 in payments from pharmaceutical and medical device companies, with $20.31 received in 2024. These payments were reported across 86 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,557).
As a Medicare-enrolled provider, Giunta has provided services to 3,701 Medicare beneficiaries, totaling 10,108 services with total Medicare billing of $860,718. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Brooklyn, NY
- Active Since 02/08/2011
- Last Updated 12/08/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1386940385
Products in Payments
- FARXIGA (Drug) $563.61
- HUMULIN (Drug) $435.75
- TRULICITY (Drug) $331.25
- Otezla (Drug) $262.07
- RAYOS (Drug) $250.02
- Dexcom CGM (Device) $210.73
- Victoza (Drug) $183.35
- Minimed 670G System (Device) $160.33
- Peripheral Orbital Atherectomy System (Device) $148.46
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $144.23
- Korlym (Drug) $125.00
- MOUNJARO (Drug) $125.00
- Prolia (Biological) $125.00
- BYDUREON (Drug) $122.00
- COSENTYX (Biological) $120.54
- JANUVIA (Drug) $118.57
- STELARA (Biological) $105.61
- V-GO (Device) $93.07
- Omnipod (Device) $88.43
- JARDIANCE (Drug) $83.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Brooklyn
Dr. Matin Sharafatkhah, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $437,076
Endocrinology, Diabetes & Metabolism $437,076
Dr. Matvey Brokhin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $373,852
Endocrinology, Diabetes & Metabolism $373,852
Dr. Robert Silver, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $354,536
Endocrinology, Diabetes & Metabolism $354,536
Alexander Perkelvald, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $343,784
Endocrinology, Diabetes & Metabolism $343,784
Dr. Iraklii Buziashvili, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $122,903
Endocrinology, Diabetes & Metabolism $122,903
Dr. Saka Kazeem, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,364
Endocrinology, Diabetes & Metabolism $23,364